Cor Vasa 2011, 53(4-5):273-277 | DOI: 10.33678/cor.2011.061

Is medical management of paediatric heart failure evidence based?

Anke Furck, Zdeněk Slavík*
Royal Brompton Hospital, Royal Brompton & Harefield NHS Foundation Trust, London, United Kingdom

Treatment of paediatric heart failure is based on much less evidence when compared with corresponding treatment in adult population. Nevertheless, successful treatment methods have been adjusted or developed for paediatric patients with chronic and acute heart failure and promising future trends exist.

Keywords: Heart failure; Paediatrics; Evidence base

Published: April 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Furck A, Slavík Z. Is medical management of paediatric heart failure evidence based? Cor Vasa. 2011;53(4-5):273-277. doi: 10.33678/cor.2011.061.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. NICE: Chronic heart failure: management of chronic heart failure in adults in primary and secondary care. www.guidance.nice.org.uk/CG108
    2. NICE: Balloon angioplasty with or without stenting for coarctation or recoarctation of aorta in adults and children. www.guidance.nice.org.uk/IPG74
    3. Packer M, Fowler MB, Roecker EB, et al. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: result of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002;106:2194-2199. Go to original source... Go to PubMed...
    4. Poole-Wilson PA, Swedberg K, Cleland JG, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET) randomised controlled trial. Lancet 2003;362:7-13. Go to original source... Go to PubMed...
    5. De Luca L, Colucci WS, Nieminen MS, et al. Evidence-based use of levosimendan in different clinical settings. Eur Heart J 2006;27:1908-1920. Go to original source... Go to PubMed...
    6. Richmond S, Wren C. Early diagnosis of congenital heart disease. Semin Neonatol 2001;6:27-35. Go to original source... Go to PubMed...
    7. Gibbs JL, Monro JL, Cunningham D, Rickards A. Survival after surgery or therapeutic catheterisation for congenital heart disease in children in the United Kingdom: analysis of the central cardiac audit database for 2000-1. BMJ 2004;328:611. Go to original source... Go to PubMed...
    8. www.CCAD.org.uk/paedanalysis
    9. Andrews RE, Fenton MJ, Ridout DA, Burch M. New-onset heart failure due to heart muscle disease in childhood: a prospective study in the United Kingdom and Ireland. Circulation 2008;117:79-84. Go to original source... Go to PubMed...
    10. Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003; 348:1647-1655. Go to original source... Go to PubMed...
    11. Wilkinson JD, Landy DC, Colan SD, et al. The pediatric cardiomyopathy registry and heart failure: key results from the first 15 years. Heart Fail Clin 2010;6:401-413. Go to original source... Go to PubMed...
    12. Lipshultz SE, Alvarez JA, Scully RE. Anthracycline associated cardiotoxicity in survivors of childhood cancer. Heart 2008;94:525-533. Go to original source... Go to PubMed...
    13. Connuck DM, Sleeper LA, Colan SD, et al. Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: A comparative study from The Pediatric Cardiomyopathy Registry. Am Heart J 2008;155:998-1005. Go to original source... Go to PubMed...
    14. van der Vorst MM, Ruis-Dudok van Heel I, Kist-van Holte JE, et al. Continuous intravenous furosemide in haemodynamically unstable children after cardiac surgery. Int Care Med 2001;27:711-715. Go to original source... Go to PubMed...
    15. van der Vorst MM, Kist JE, van der Heiiden AJ, Burggraf J. Diuretics in pediatrics: current knowledge and future prospects. Paediatr Drugs 2006; 8:245-264. Go to original source... Go to PubMed...
    16. Gisler F, Knirsch W, Harpes P, Bauersfeld U. Effectiveness of angiotensin-converting enzyme inhibitors in pediatric patients with mid to severe aortic valve regurgitation. Pediatr Cardiol 2008;29:906-909. Go to original source... Go to PubMed...
    17. Mori Y, Nakazawa M, Tomimatsu H, Momma K. Long-term effect of angiotensin-converting enzyme inhibitor in volume overloaded heart during growth: a controlled pilot study. Am Coll Cardiol 2000;36:270-275. Go to original source... Go to PubMed...
    18. Calabro R, Pisacane C, Pacileo G, Russo MG. Hemodynamic effect of a single oral dose of enalapril among children with asymptomatic chronic mitral regurgitation. Am Heart J 1999;138:955-961 Go to original source... Go to PubMed...
    19. Alehan D, Ozkutlu S. Beneficial effect of 1-year captopril therapy in children with chronic aortic regurgitation who have no symptoms. Am Heart J 1998;135:598-603. Go to original source... Go to PubMed...
    20. Hsu DT, Zak V, Mahony L, et al. Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation 2010;122:333-340. Go to original source... Go to PubMed...
    21. Silva JN, Canter CE. Current management of pediatric dilated cardiomyopathy. Curr Opin Cardiol 2010;25:80-87. Go to original source... Go to PubMed...
    22. Albers S, Meibohm B, Mir TS, Laer S. Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with heart failure. Br J Clin Pharmacol 2007;65:511-522. Go to original source... Go to PubMed...
    23. Bruns LA, Chrisant MK, Lamour JM, et al. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. J Pediatr 2001;138:505-511. Go to original source... Go to PubMed...
    24. Azeka E, Franchini Ramirez JA, Valler C, Alcides Bocchi E. Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment. J Am Coll Cardiol 2002;40:2034-2038. Go to original source... Go to PubMed...
    25. Williams RV, Tani LY, Shaddy RE. Intermediate effects of treatment with metoprolol or carvedilol in children with left ventricular systolic dysfunction. J Heart Lung Transplant 2002;21:906-909. Go to original source... Go to PubMed...
    26. Buckhorn R, Hulpke-Wette M, Ruschewski W, et al. Effects of therapeutic beta blockade on myocardial function and cardiac remodelling in congenital cardiac disease. Cardiol Young 2003;13:36-43. Go to original source... Go to PubMed...
    27. Rusconi P, Gomez-Arin O, Rossique-Gonzales M, et al. Carvedilol in children with cardiomyopathy: 3-year experience at a single institution. J Heart Lung Transplant 2004;23:832-838. Go to original source... Go to PubMed...
    28. Blume ED, Canter CE, Spicer R, et al. Prospective, single-arm protocol of carvedilol in children with ventricular dysfunction. Pediatr Cardiol 2006; 27:336-342. Go to original source... Go to PubMed...
    29. Shaddy RE, Boucek MM, Hsu DT, et al. Carvedilol for children and adolescents with heart failure. JAMA 2007;298:1171-1179. Go to original source... Go to PubMed...
    30. Bajcetic M, Kokic Nikolic A, Djukic M, et al. Effects of carvedilol on left ventricular function and oxidative stress in infants and children with idiopathic dilated cardiomyopathy: a 12-month, two-center, open-label study. Clin Ther 2008;30:702-714. Go to original source... Go to PubMed...
    31. Kantor PF, Abraham JR, Dipchand AI, et al. The impact of changing medical therapy on transplantation-free survival in pediatric dilated cardiomyopathy. J Am Coll Cardiol 2010;55:1377-1384. Go to original source... Go to PubMed...
    32. Parr GV, Blackstone EH, Kirklin JW. Cardiac performance and mortality early after intracardiac surgery in infants and young children. Circulation 1975;51:867-874. Go to original source... Go to PubMed...
    33. Wernovsky G, Wypij D, Jonas RA, et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 1995;92:2226-2235. Go to original source... Go to PubMed...
    34. Hoffman TM, Wernovsky G, Atz AM, et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 2003; 107:996-1002. Go to original source... Go to PubMed...
    35. Chang AC, Atz AM, Wernovsky G, et al. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med 1995;23:1907-1914. Go to original source... Go to PubMed...
    36. Duggal B, Pratap U, Slavik Z, et al. Milrinone and low cardiac output following cardiac surgery in infants: Is there a direct myocardial effect? Pediatr Cardiol 2005;26:1-5. Go to original source... Go to PubMed...
    37. Singh VK, Sharma R, Agrawal A, Varma A. Vasopressin in the pediatric cardiac intensive care unit: Myth or reality. Ann Pediatr Card 2009;2:65-73. Go to original source... Go to PubMed...
    38. Matok I, Vardi A, Augarten A, et al. Beneficial effects of terlipressin in prolonged pediatric cardiopulmonary resuscitation: A case series. Crit Care Med 2007;35:1161-1164. Go to original source... Go to PubMed...
    39. Davies RR, Russo MJ, Hong KN, et al. The use of mechanical circulatory support as a bridge to transplantation on pediatric patients: an analysis of the United Network for Organ Sharing Database. J Thorac Cardiovasc Surg 2008;135:421-427. Go to original source... Go to PubMed...
    40. Rajagopal SK, Almond CS, Laussen PC, et al. Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization Registry. Crit Care Med 2010;38:382-387. Go to original source... Go to PubMed...
    41. Zimmerman H, Covington D, Smith R, et al. Recovery of dilated cardiomyopathies in infants and children using left ventricular assist device. ASAIO J 2010;56:364-368. Go to original source... Go to PubMed...
    42. Nahum E, Dagan O, Lev A, et al. Favorable outcome of pediatric fulminant myocarditis supported by extracorporeal membranous oxygenation. Pediatr Cardiol 2010;31:1059-1063. Go to original source... Go to PubMed...
    43. Groetzner J, Reichart B, Roemer U, et al. Cardiac transplantation in pediatric patients: fifteen-year experience of a single center. Ann Thorac Surg 2005; 79:53-60. Go to original source... Go to PubMed...
    44. Phelps CM, Tissot C, Buckvold S, et al. Outcome of acute graft rejection associated with hemodynamic compromise in pediatric heart transplant recipients. Pediatr Cardiol 2011;32:1-7. Go to original source... Go to PubMed...
    45. Webber SA, Naftel DC, Parker J, et al. Late rejection episodes more than 1 year after pediatric heart transplantation: risk factors and outcomes. J Heart Lung Transplant 2003;22:869-875. Go to original source... Go to PubMed...
    46. Zuppan CW, Wells LM, Kerstetter JC, et al. Cause of death in pediatric and infant heart transplant recipients: review of a 20-year, single-institution cohort. J Heart Lung Transplant 2009;28:579-584. Go to original source... Go to PubMed...
    47. O'Sullivan JJ, Roche SL, Crossland DS, et al. Recovery of heart function in children with acute severe heart failure. Transplantation 2008;85:975-979. Go to original source... Go to PubMed...
    48. Amabile N, Fraisse A, Bouvenot J, et al. Outcome of acute fulminant myocarditis in children. Heart 2006;92:1269-1273. Go to original source... Go to PubMed...
    49. Daftari B, Alejos JC, Perens G. Initial experience with sildenafil, bosentan, and nitric oxide for pediatric cardiomyopathy patients with elevated pulmonary vascular resistance before and after orthotopic heart transplantation. J Transplant 2010;2010:656984. Go to original source... Go to PubMed...
    50. Namachivayam P, Crossland DS, Butt WW, Shekedermian LS. Early experience with levosimendan in children with ventricular dysfunction. Pediatr Crit Care Med 2006;7:445-448. Go to original source... Go to PubMed...
    51. Lechner E, Moosbauer W, Pinter M, et al. Use of levosimendan a new inodilator, for postoperative myocardial stunning in premature neonate. Pediatr Crit Care Med 2007;8:61-63. Go to original source... Go to PubMed...
    52. Di Chiara L, Ricci Z, Garisto C, et al. Initial experience with levosimendan infusion for preoperative management of hypoplastic left heart syndrome. Pediatr Cardiol 2010;31:166-167. Go to original source... Go to PubMed...
    53. Egan JR, Clarke AJ, Williams S, et al. Levosimendan for low cardiac output: a pediatric experience. J Intensive Care Med 2006;21:183-187. Go to original source... Go to PubMed...
    54. Simsic JM, Mahle WT, Cuadrado A, et al. Hemodynamic effects and safety of nesiritide in neonates with heart failure. J Intensive Care Med 2008;23:389-395. Go to original source... Go to PubMed...
    55. Kharbanda RK, Nielsen TT, Redington AN. Translation of remote ischaemic preconditioning into clinical practice. Lancet 2009;374:1557-1565. Go to original source... Go to PubMed...
    56. Konstantinov IE, Arab S, Li J, et al. The remote ischemic preconditioning stimulus modifies gene expression in mouse myocardium. J Thorac Cardiovasc Surg 2005;130:1326-1332. Go to original source... Go to PubMed...
    57. Cheung MM, Kharbanda RK, Konstantinov IE, et al. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 2006;47:2277-2282. Go to original source... Go to PubMed...
    58. Zhou W, Zeng D, Chen R, et al. Limb ischemic preconditioning reduces heart and lung injury after an open heart operation in infants. Pediatr Cardiol 2010;31:22-29. Go to original source... Go to PubMed...
    59. Quintana M, Kahan T, Hjemdahl P, et al. Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent. Am J Cardiovasc Drugs 2004;4:159-167. Go to original source... Go to PubMed...
    60. Warner DS. Pharmacologic protection from ischemic neuronal injury. J Neurosurg Anesthesiol 2004;16:95-97. Go to original source... Go to PubMed...
    61. Peng TI, Jou MJ. Oxidative stress caused by mitochondrial calcium overload. Ann N Y Acad Sci 2010;1201:183-188. Go to original source... Go to PubMed...
    62. Matsubara M, Ranji M, Leshnower BG, et al. In vivo fluorometric assessment of cyclosporine on mitochondrial function during myocardial ischemia and reperfusion. Ann Thorac Surg 2010;89:1532-1537. Go to original source... Go to PubMed...
    63. Pratap U, Slavik Z, Ofoe V, et al. Pediatric cardiopulmonary resuscitation and cyclosporin A - is there a clinical benefit? Čes-Slov Pediatr 2004;59:605-609.
    64. Sullivan PG, Thompson M, Scheff SW. Continuous infusion of cyclosporin A postinjury significantly ameliorates cortical damage following traumatic brain injury. Exp Neurol 2000;161:631-637. Go to original source... Go to PubMed...
    65. Nathan M, Friehs I, Choi YH, et al. Cyclosporin A but not FK-506 protects against dopamine-induced apoptosis in the stunned heart. Ann Thorac Surg 2005;79:1620-1626. Go to original source... Go to PubMed...
    66. Ivanes F, Mewton N, Rioufol G, et al. Cardioprotection in the clinical setting. Cardiovasc Drugs Ther 2010;24:281-287. Go to original source... Go to PubMed...
    67. Olgunturk R, Kula S, Sucak GT, et al. Peripheric stem cell transplantation in children with dilated cardiomyopathy: preliminary report of first two cases. Pediatr Transplant 2010;14:257-260. Go to original source... Go to PubMed...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes